IMMX Immix: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik Immix Biopharma Inc. (IMMX)

The EV/Revenue multiple for Immix Biopharma, Inc. (IMMX) demonstrates moderate dynamics, supported by the recruitment of leading oncologists to develop innovative drugs. The 0.00 level reflects the current value of this metric. Meanwhile, the business relies on external contractors for production and trials, while project development is funded through the gradual expenditure of existing capital and grants.

Nilai perusahaan marang pendapatan: Immix (IMMX) kanggo 23.11.2025 - 20.11.2026

Immix - rincian analitis lan metrik utama (IMMX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Immix Biopharma Inc. IMMX
Sampel barang Immix Biopharma Inc.

To objectively analyze asset value, a manager must correlate the total enterprise value with operating income, excluding the impact of debt load. By analyzing the enterprise value-to-revenue ratio, an investor identifies business overvaluation, which is critical for Immix Biopharma, Inc. (IMMX) during the development stage of its NXC-201 CAR-T therapy, where the absence of mass sales may create a dangerous gap between capitalization and actual cash flows.

Analisis pesaing Immix Biopharma, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP